Instil Bio annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Instil Bio Depreciation & Amortization Growth & History (TIL)
Instil Bio's depreciation and amortization was $534,000 for fiscal 2025.
View full Instil Bio company overviewInstil Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $534,000 | −$3.1M | −85.21% |
| 2024 | 2024-12-31 | $3.6M | −$1.1M | −24.10% |
| 2023 | 2023-12-31 | $4.8M | −$1.2M | −20.56% |
| 2022 | 2022-12-31 | $6.0M | $3.2M | +117.55% |
| 2021 | 2021-12-31 | $2.8M | $2.5M | +975.00% |
| 2020 | 2020-12-31 | $256,000 | — | — |
Instil Bio quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $248,000 | $236,000 | +1966.67% |
| Q1 2026 | 2026-03-31 | $12,000 | −$486,000 | −97.59% |
| Q4 2025 | 2025-12-31 | $12,000 | — | — |
| Q3 2025 | 2025-09-30 | $12,000 | −$889,000 | −98.67% |
| Q2 2025 | 2025-06-30 | $12,000 | −$963,000 | −98.77% |
| Q1 2025 | 2025-03-31 | $498,000 | −$495,000 | −49.85% |
| Q3 2024 | 2024-09-30 | $901,000 | −$52,000 | −5.46% |
| Q2 2024 | 2024-06-30 | $975,000 | −$16,000 | −1.61% |
| Q1 2024 | 2024-03-31 | $993,000 | −$783,000 | −44.09% |
| Q3 2023 | 2023-09-30 | $953,000 | −$986,000 | −50.85% |
| Q2 2023 | 2023-06-30 | $991,000 | −$59,000 | −5.62% |
| Q1 2023 | 2023-03-31 | $1.8M | $877,000 | +97.55% |
| Q3 2022 | 2022-09-30 | $1.9M | $1.2M | +153.80% |
| Q2 2022 | 2022-06-30 | $1.1M | $394,000 | +60.06% |
| Q1 2022 | 2022-03-31 | $899,000 | $460,000 | +104.78% |
| Q3 2021 | 2021-09-30 | $764,000 | $697,000 | +1040.30% |
| Q2 2021 | 2021-06-30 | $656,000 | $622,000 | +1829.41% |
| Q1 2021 | 2021-03-31 | $439,000 | $432,000 | +6171.43% |
| Q3 2020 | 2020-09-30 | $67,000 | — | — |
| Q2 2020 | 2020-06-30 | $34,000 | — | — |
| Q1 2020 | 2020-03-31 | $7,000 | — | — |
Instil Bio depreciation and amortization trends
Over the last five fiscal years, Instil Bio's depreciation and amortization increased from $256,000 to $534,000, a change of $278,000. The latest reported quarter, Q2 2026, shows $248,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Instil Bio source filings ↗